Famous actress Elçin Sangu made the series deal for the new season. The actress, who is preparing to meet her fans with the production called Yalancılar ve Mumları, which Medyapım has been meticulously preparing for a long time, will soon start working on the set.
Elçin Sangu, upon the question of the reporters who were wondering about the health status of the actress who went to the hospital frequently in the last days, said that he went for some checkups, but it was nothing important. The actress stated that he talked to the doctor about the issues that may occur after the vaccine. Expressing that she did not have any health problems, the actress also attracted attention with her new hair style.
Elçin Sangu, who is likened to Sinem Kobal in this state, said, “I’m already trying to get used to it, since I haven’t dyed my hair for years… Even I find it strange when I do something like this for the first time, I’m just getting used to it. We will get used to it, I like it,” she said.
An impressive cast met in Yalancılar ve Mumları, a remarkable series of the new season. Elçin Sangu, who was stated to portray the character of Leyla, corrected the erroneous information on this subject.
Elçin Sangu stated that her character’s name is not Leyla, but Ceyda. As it will be remembered, the name of the character in the series İyi Günde Kötü Günde, in which the famous actress took part last season, was also Leyla. Fans also commented that this could be bad luck in the new project.
However, Elçin Sangu, who announced for the first time that the character’s name in the series is Ceyda, corrected the erroneous information on this subject.
Explaining that the series will start in September and it will be good, Elçin Sangu stated that it is also a good thing to work with Fatih Aksoy, the owner of Medyapım.
Elçin Sangu’s co-stars in the new series include the following names: Ceren Moray, Feyyaz Duman, Şafak Pekdemir, Melike Göner, İlker Kızmaz, İsmail Demirci…
As you can see, the series, which brings together many famous names, is expected to meet the audience on Fox TV in September.